Table 5:

Duration of Hospitalisation, ICU, Mechanical Ventilation, ECMO, and ARDS Among Those Requiring the Support at Randomisation, and Escalation of Clinical Support Measures During the Study.

	High-titre (n=91)	Low-titre (n=47)	p value
Duration of initial in-hospital treatment (days)
Patients receiving intervention at randomisation (n)	91	47	··
Median (IQR)	5 (3–12)	6 (4–12)	0·30
Duration of initial intensive care treatment (days)
Patients receiving intervention at randomisation (n)	40	20	··
Median (IQR)	5·0 (3·0–12·5)	8 (4–25)	0·32
Duration of initial mechanical ventilation (days)
Patients receiving intervention at randomisation (n)	25	14	··
Median (IQR)	9 (4–16)	15·5 (7·0–29·0)	0·22
Duration of extracorporeal membrane oxygenation (days)*
Patients receiving intervention at randomisation (n)	5	1	··
Median (IQR)	16 (14–18)	20 (20–20)	··
Duration of acute respiratory distress syndrome (days)*
Patients with condition at randomisation (n)	15	3	··
Median (IQR)	9 (4–15)	8 (4–29)	··

p values were calculated with Wilcoxon’s test.

^*Estimates from Wilcoxon’s test are not provided because of the small population size of the low-titre group.